• Smit Deliwala, Saira Sundus, Tarek Haykal, Nikita Theophilus, and Ghassan Bachuwa.
• Internal Medicine, Hurley Medical Center, Michigan State University, College of Human Medicine, Flint, USA.
• Cureus. 2020 Apr 2; 12 (4): e7513.

Abstract2019 has been a landmark year in the world of electronic nicotine delivery systems (ENDS), specifically e-cigarette and vaping. Numerous state health departments across the United States have voiced their concerns in the growing number of lung injury cases from e-cigarettes and vaping. Over the past few decades, many agencies have brought into light the harmful effects of smoking cigarettes, and despite popular belief, a growing movement has started to recognize the harmful effects of ENDS. The Centers for Disease Control and Prevention have released recommendations and provided health practitioners a methodology to identify and diagnose e-cigarette, or vaping, product use-associated lung injury (EVALI). EVALI is a diagnosis of exclusion and comprises a variety of respiratory illnesses, with intubation rates nearing 32%. The most critical risk factor remains product use in the preceding 90 days, although a timeline on the development of symptoms or notable structural changes remains unknown. We present a case of acute lung injury in a traditional cigarette smoker that evolved within hours of switching to e-cigarettes.Copyright © 2020, Deliwala et al.

8 keywords...

hide…